Journal of the American Academy of Dermatology
Cutaneous ultraviolet exposure and its relationship to the development of skin cancer
Section snippets
Relationship of UV exposure to skin cancer development
The skin is the most exposed organ to environmental UV and to the associated sequellae.2 Exposure to UV radiation on the skin results in clearly demonstrable mutagenic effects. The p53 suppressor gene, which is frequently mutated in skin cancers, is believed to be an early target of the UV radiation–induced neoplasm.3 Although there is no direct way that the active wavelengths for the development of skin cancer in human beings can be determined, there is ample indirect evidence demonstrating
Summary
There are now many studies that provide a firm basis for the association of UV exposure with the development of skin cancer. Yet, a variety of questions remain regarding the exact basis for this relationship. Hopefully, we will have even more definitive answers to questions related to the optimization of effectiveness of UV photoprotection and for reducing the risk from exposure to UV radiation as improved photoprotective agents, strategies, and methods are developed in the future.
References (43)
- et al.
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis
Mayo Clin Proc
(2007) - et al.
Epidemiology of skin cancer
Photochem Photobiol
(2001) - et al.
Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the EUROCARE group of registries
Eur J Cancer
(2005) - et al.
Effects of altitude and latitude on ambient UVB radiation
J Am Acad Dermatol
(1999) - et al.
Lower body anatomical distribution of solar ultraviolet radiation on the human form in standing and sitting postures
J Photochem Photobiol B
(2003) - et al.
Cancer risks in Nordic immigrants and their offspring in Sweden
Eur J Cancer
(2002) - et al.
Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial
Lancet
(1999) - et al.
Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic
J Am Acad Dermatol
(1999) - et al.
The Eastern Australian childhood nevus study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype
J Am Acad Dermatol
(2003) - et al.
Relative importance of prior basal cell carcinomas. Continuing sun exposure, and circulating lymphocytes-T on the development of basal cell carcinoma
J Invest Dermatol
(1992)
The effect of sunscreen on melanoma risk
Dermatol Clin
Comparison of UVA protection afforded by high sun protection factor sunscreens
J Am Acad Dermatol
Hat-wearing patterns in persons attending baseball games
J Am Acad Dermatol
Malignant melanoma: prevention, early detection, and treatment in the 21st century
CA Cancer J Clin
Skin DNA photodamage and its biological consequences
J Am Acad Dermatol
UV radiation specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma
Natl Cancer Inst
Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice
Cancer Res
Wavelengths effective in induction of malignant melanoma
Proc Natl Acad Sci U S A
Dose response for ultraviolet radiation A-induced focal melanocytic hyperplasia and nonmelanoma skin tumors in Monodelphis domestica
Photochem Photobiol
The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review
Int J Cancer
Cited by (0)
Supported by L'Oréal.
Disclosure: Dr Rigel has served in the past as a consultant for sunscreen evaluation for L'Oréal; La Roche Posay; Neutrogena; Johnson and Johnson; Beiersdorf; and Proctor and Gamble.
Reprints not available from the author.